Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy
Authors:
- Amin Faisal EllakwaAEAmin Faisal Ellakwa
- Azmy ElshazlyAEAzmy Elshazly
- Kelany AbdelhameedKAKelany Abdelhameed
- Abdelsatar ElghobashyAEAbdelsatar Elghobashy
- Mohammed EldalyMEMohammed Eldaly
Open Access
- 1 July 2012
- journal article
- research article
- Published by Taylor & Francis in The Application of Clinical Genetics
- Vol. 5, 55-65
Abstract
Background: Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus. It has been suggested that nitric oxide (NO) and α2β1 integrin (a platelet receptor for collagen) play an important role in the pathogenesis of microvascular complications in DR. Aim: The aim of this study was to investigate the association of two candidate genes involved in the regulation of retinal vasculature, endothelial nitric oxide synthase (eNOS) and α2β1 integrin (ITGA2) genes, with the development of DR in Egyptian patients with type 2 diabetes mellitus and to investigate whether genetic variants will affect the type of retinopathy (proliferative or nonproliferative). Methods: In this study, 70 patients were enrolled and categorized into two groups: (1) a DR group consisting of 50 patients with DR, which was further subclassified into 25 patients with nonproliferative DR (NPDR group) and 25 patients with proliferative DR (PDR group) and (2) a diabetes without retinopathy (DWR) group, comprising 20 patients with type 2 diabetes of more than 10 years' duration who showed no signs of DR. Associations of the genetic polymorphisms of eNOS (G894T) and ITGA2 (BgI II) were studied. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed for all samples to evaluate the genotypes and correlate with the phenotype of the disease. Results: The allele frequencies of both polymorphisms showed considerable differences between patients with and without DR. The GG genotype of G894T polymorphism of eNOS was associated with a 9.75-fold increased risk of DR (95% confidence interval 1.7–55.4) and the genotype ITGA2 BgI II (+/+) was associated with a 10.1-fold increased risk of DR (95% confidence interval 1.8–57.9), while the α2β1 integrin gene polymorphism of genotype distribution of both eNOS and ITGA2 polymorphisms did not differ significantly between the proliferative and nonproliferative DR groups. Conclusion: A significant association between the G894T polymorphism of eNOS and BgI II polymorphism of ITGA2 genes and DR was observed, while there was no association between the genetic variants of those two polymorphisms and the type of retinopathy.Keywords
This publication has 38 references indexed in Scilit:
- Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: responseDiabetology & Metabolic Syndrome, 2010
- Human Genetics of Diabetic Retinopathy: Current PerspectivesJournal of Ophthalmology, 2010
- Methylentetrahydrofolate Reductase and Nitric Oxide Synthase Polymorphism in Patients with Atherosclerosis and DiabetesPathology and Oncology Research, 2009
- EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes2008
- Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialThe Lancet, 2007
- Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal diseaseNephrology Dialysis Transplantation, 2004
- Molecular genetics of microvascular disease in diabetic retinopathyEye, 2003
- Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart diseaseJournal of Molecular Medicine, 2000
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972
- A Simple Procedure for Human Lymphocyte Isolation from Peripheral BloodTissue Antigens, 1972